We are live on ! Find out more
NIVF icon

NewGenIvf

1 hedge funds and large institutions have $15 invested in NewGenIvf in 2026 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% less funds holding

Funds holding: 4 → 1 (-3)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

100% less capital inflows, than outflows

Capital inflows: $201 | Capital outflows: $139K

Holders
1
Holders Change
-3
Holders Change %
-75%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

NIVF Hedge Fund Activity: Q3 2026 in Review

1 of the 8,192 institutional investors tracked by Wall St. Rank reported a position in NewGenIvf (NIVF) for Q3 2026, worth a combined $15 — down 100% from $139K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of NIVF and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was SBI Securities, opening a new position worth an estimated $201. The largest seller was HRT Financial, exiting entirely with an estimated $94K sold.

  • 1 institutional investor held NewGenIvf (NIVF) as of Q3 2026, down from 4 in Q2 2026.
  • Funds reported $15 of NewGenIvf stock for Q3 2026, down 100% quarter-over-quarter.
  • 1 fund opened new NewGenIvf positions in Q3 2026 and 4 closed out, a net change of -3 holders.
  • The largest NewGenIvf buyer in Q3 2026 was SBI Securities, an estimated $201 added.
  • The largest NewGenIvf seller in Q3 2026 was HRT Financial, an estimated $94K sold.

Based on aggregated 13F filings for Q3 2026.